Embecta Corp. Common Stock

EMBCNASDAQUSD
3.38 USD
0.03 (0.88%)AT CLOSE (11:59 AM EDT)
3.41
0.03 (0.77%)
POST MARKET (AS OF 07:08 PM EDT)
Post Market
AS OF 07:08 PM EDT
3.41
0.03 (0.77%)
🔴Market: CLOSED
Open?$3.40
High?$3.48
Low?$3.37
Prev. Close?$3.41
Volume?1.4M
Avg. Volume?3.0M
VWAP?$3.40
Rel. Volume?0.46x
Bid / Ask
Bid?$2.94 × 100
Ask?$3.86 × 100
Spread?$0.92
Midpoint?$3.40
Valuation & Ratios
Market Cap?202.3M
Shares Out?59.3M
Float?58.6M
Float %?98.8%
P/E Ratio?1.81
P/B Ratio?-0.32
EPS?$1.89
Dividend?17.45%
Ex-Dividend?N/A

Shares of Embecta Corp. Common Stock (EMBC) are trading at $3.39. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest EMBC is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Employees
1.9K
Market Cap
202.3M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2022-03-21
Address
300 KIMBALL DRIVE
PARSIPPANY, NJ 07054
Phone: (862) 401-0000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
28
Momentum?
27
Short Sent.?
63
Piotroski F-Score?2/9Weak
Altman Z-Score?1.77Distress
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.18%High
Short Interest?7.1M
Days to Cover?1.4
Free Float58.6M
Avg Daily Volume5.2M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.42Strong
Quick Ratio?1.65Adequate
Cash Ratio?0.75Adequate
Debt/Equity?-2.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
1.8CHEAP
P/B?
S&P
97
-0.32CHEAP
P/S?
Peers
100
S&P
97
0.19CHEAP
P/FCF?
Peers
100
S&P
97
1.0CHEAP
EV/EBITDA?
Peers
100
S&P
97
4.5CHEAP
EV/Sales?
Peers
100
S&P
87
1.32CHEAP
Returns & Efficiency
ROE?
S&P
8
-17.9%WEAK
ROA?
Peers
50
S&P
77
10.9%STRONG
Cash Flow & Enterprise
FCF?$204.7M
Enterprise Value?$1.4B
Fundamentals ratios updated end of day